QuantumSi Inc - Asset Resilience Ratio
QuantumSi Inc (QSI) has an Asset Resilience Ratio of 42.72% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check QSI strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2020–2025)
This chart shows how QuantumSi Inc's Asset Resilience Ratio has changed over time. See how leveraged is QuantumSi Inc's balance sheet to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down QuantumSi Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see QuantumSi Inc (QSI) total market value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $91.14 Million | 42.72% |
| Total Liquid Assets | $91.14 Million | 42.72% |
Asset Resilience Insights
- Very High Liquidity: QuantumSi Inc maintains exceptional liquid asset reserves at 42.72% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
QuantumSi Inc Industry Peers by Asset Resilience Ratio
Compare QuantumSi Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Dirui Industrial Co Ltd
SHE:300396 |
Medical Devices | 6.89% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
Annual Asset Resilience Ratio for QuantumSi Inc (2020–2025)
The table below shows the annual Asset Resilience Ratio data for QuantumSi Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 57.52% | $141.27 Million | $245.61 Million | -7.18pp |
| 2024-12-31 | 64.70% | $160.36 Million | $247.87 Million | +23.16pp |
| 2023-12-31 | 41.53% | $123.88 Million | $298.25 Million | -26.67pp |
| 2022-12-31 | 68.20% | $266.99 Million | $391.49 Million | -18.35pp |
| 2021-12-31 | 86.55% | $435.52 Million | $503.23 Million | -- |
| 2020-12-31 | 0.00% | $0.00 | $40.59 Million | -- |
About QuantumSi Inc
Quantum-Si incorporated, a life sciences company, develops proprietary, universal, and single-molecule detection platform applied to proteomics to enable next-gen protein sequencing (NGPS). The company offers Platinum and Platinum Pro NGPS instruments for single-molecule, amino acid level resolution, and automated data analysis; library preparation kits to prepare a customer's protein sample for … Read more